The Use of Proteomics in Biomarker Discovery in Neurodegenerative Diseases
Biomarkers for neurodegenerative diseases should reflect the central pathogenic processes of the diseases. The field of clinical proteomics is especially well suited for discovery of biomarkers in cerebrospinal fluid (CSF), which reflects the proteins in the brain under healthy conditions as well as...
| Main Authors: | , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
IOS Press
2005
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3850612/ |